State Key Laboratory of Food Science and Technology, Nanchang University, Nanchang, China.
Crit Rev Food Sci Nutr. 2023 Nov;63(33):12578-12596. doi: 10.1080/10408398.2022.2103090. Epub 2022 Jul 27.
The outbreak of the COVID-19 pandemic has brought great problems to mankind, including economic recession and poor health. COVID-19 patients are frequently reported with gastrointestinal symptoms such as diarrhea and vomiting in clinical diagnosis. Maintaining intestinal health is the key guarantee to maintain the normal function of multiple organs, otherwise it will be a disaster. Therefore, the purpose of this review was deeply understanded the potential mechanism of SARS-CoV-2 infection threatening intestinal health and put forward reasonable treatment strategies. Combined with the existing researches, we summarized the mechanism of SARS-CoV-2 infection threatening intestinal health, including intestinal microbiome disruption, intestinal barrier dysfunction, intestinal oxidative stress and intestinal cytokine storm. These adverse intestinal events may affect other organs through the circulatory system or aggravate the course of the disease. Typically, intestinal disadvantage may promote the progression of SARS-CoV-2 through the gut-lung axis and increase the disease degree of COVID-19 patients. In view of the lack of specific drugs to inhibit SARS-CoV-2 replication, the current review described new strategies of probiotics, prebiotics, postbiotics and nutrients to combat SARS-CoV-2 infection and maintain intestinal health. To provide new insights for the prevention and treatment of gastrointestinal symptoms and pneumonia in patients with COVID-19.
新型冠状病毒肺炎(COVID-19)疫情的爆发给人类带来了巨大的问题,包括经济衰退和健康状况不佳。在临床诊断中,经常有 COVID-19 患者报告出现腹泻和呕吐等胃肠道症状。维护肠道健康是维持多个器官正常功能的关键保障,否则将是一场灾难。因此,本综述的目的是深入了解 SARS-CoV-2 感染威胁肠道健康的潜在机制,并提出合理的治疗策略。结合现有研究,我们总结了 SARS-CoV-2 感染威胁肠道健康的机制,包括肠道微生物失调、肠道屏障功能障碍、肠道氧化应激和肠道细胞因子风暴。这些不良的肠道事件可能通过循环系统影响其他器官,或加重疾病进程。通常情况下,肠道不利因素可能通过肠-肺轴促进 SARS-CoV-2 的进展,并增加 COVID-19 患者的疾病严重程度。鉴于缺乏特异性抑制 SARS-CoV-2 复制的药物,本综述描述了益生菌、益生元、后生元和营养素等新策略,以对抗 SARS-CoV-2 感染并维持肠道健康。为预防和治疗 COVID-19 患者的胃肠道症状和肺炎提供新的思路。